School of Psychology.
University Affiliated Hospital Hotel- Dieu de Levis Research Centre.
Health Psychol. 2018 Sep;37(9):828-838. doi: 10.1037/hea0000632.
We sought to reduce the 90% rate of missed diagnoses of panic-like anxiety (panic attacks with or without panic disorder) among emergency department patients with low risk noncardiac chest pain by validating and improving the Panic Screening Score (PSS).
A total of 1,102 patients with low risk noncardiac chest pain were prospectively and consecutively recruited in two emergency departments. Each patient completed a telephone interview that included the PSS, a brief 4-item screening instrument, new candidate predictors of panic-like anxiety, and the Anxiety Disorder Interview for the Diagnostic and Statistical Manual of Mental Disorders. Fourth Edition to identify panic-like anxiety.
The original 4-item PSS demonstrated a sensitivity of 51.8% (95% CI [48.4, 57.0]) and a specificity of 74.8% (95% CI [71.3, 78.1]) for panic-like anxiety. Analyses prompted the development of the Revised-PSS; this 6-item instrument was 19.1% (95% CI [12.7, 25.5]) more sensitive than the original PSS in identifying panic-like anxiety in this sample (χ2(1, N = 351) = 23.89 p < .001) while maintaining a similar specificity (χ2(1, N = 659) = 0.754, p = .385; 0.4%, 95% CI [-3.6, 4.5]). The discriminant validity of the Revised-PSS proved stable over the course of a 10-fold cross-validation.
The Revised-PSS has significant potential for improving identification of panic-like anxiety in emergency department patients with low risk noncardiac chest pain and promoting early access to treatment. External validation and impact analysis of the Revised-PSS are warranted prior to clinical implementation. (PsycINFO Database Record
通过验证和改进惊恐筛查评分(PSS),降低急诊科低危非心源性胸痛患者中惊恐样焦虑(伴有或不伴有惊恐障碍的惊恐发作)的 90%漏诊率。
前瞻性连续招募了 2 家急诊科的 1102 例低危非心源性胸痛患者。每位患者均完成了电话访谈,内容包括 PSS、简短的 4 项筛查工具、新的惊恐样焦虑预测因子,以及《精神障碍诊断与统计手册》第四版焦虑障碍访谈。
原始的 4 项 PSS 对惊恐样焦虑的敏感性为 51.8%(95%CI [48.4, 57.0]),特异性为 74.8%(95%CI [71.3, 78.1])。分析结果促使修订版 PSS 的发展;该 6 项量表在识别该样本中的惊恐样焦虑方面比原始 PSS 敏感 19.1%(95%CI [12.7, 25.5])(χ2(1, N = 351) = 23.89,p <.001),同时保持相似的特异性(χ2(1, N = 659) = 0.754,p =.385;0.4%,95%CI [-3.6, 4.5])。修订版 PSS 的判别效度在 10 倍交叉验证过程中保持稳定。
修订版 PSS 具有显著提高急诊科低危非心源性胸痛患者惊恐样焦虑识别能力并促进早期治疗的潜力。在临床实施之前,需要对修订版 PSS 进行外部验证和影响分析。